Latest Breaking News On - Rossari biotech limited - Page 2 : comparemela.com

Rossari Biotech Limited subsidiary to expand Ethoxylation Capacity

Rossari Biotech Limited subsidiary to expand Ethoxylation Capacity
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Board of directors unitop chemicals privateRossari biotechRossari biotech limitedUnitop chemicals private limitedEthoxylation capacity

Rossari Biotech Consolidated Revenue From Operation At ₹410 6 Cr in Q1FY24

Rossari Biotech Consolidated Revenue From Operation At ₹410 6 Cr in Q1FY24
freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.

Edward menezesRossari biotech limited onRossari biotechRossari biotech limitedExecutive chairmanSunil chariBiotech limited

Rossari Biotech Ltd Q1FY24 consolidated PAT up at Rs 29 21 crores

Rossari Biotech Ltd Q1FY24 consolidated PAT up at Rs 29 21 crores
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Rossari biotechRossari biotech ltdBiotech limitedRossari biotech limited

Rossari Biotech Limited recommends final dividend of Rs 0 50

The Board of Directors of Rossari Biotech Limited have, at their meeting held today, has recommended Final Dividend of 25% i.e. Re. 0.50/- per share on Equity Shares of the Face Value of Rs. 2/- each for the Financial Year ended March 31, 2023.

Rossari biotechBoard of directors rossari biotechRossari biotech limitedFinal dividendEquity sharesFace valueFinancial yearAnnual general meeting

Rossari Biotech Ltd posts rise in consolidated PAT to Rs 28 97 crores in Q4FY23

The Board of Directors of Rossari Biotech Limited, at its meeting held today have approved the financial results of the company for the period ended March 31, 2023 - Q4FY23 and FY2023.

Rossari biotechRossari biotech ltdBiotech limitedYear endedFinancial yearRossari biotech limited